Your browser doesn't support javascript.
loading
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization.
Gardner, Alycia; de Mingo Pulido, Álvaro; Hänggi, Kay; Bazargan, Sarah; Onimus, Alexis; Kasprzak, Agnieszka; Conejo-Garcia, Jose R; Rejniak, Katarzyna A; Ruffell, Brian.
Afiliación
  • Gardner A; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • de Mingo Pulido Á; Cancer Biology PhD Program, University of South Florida, Tampa, Florida, USA.
  • Hänggi K; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Bazargan S; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Onimus A; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Kasprzak A; Cancer Biology PhD Program, University of South Florida, Tampa, Florida, USA.
  • Conejo-Garcia JR; Department of Immunology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Rejniak KA; Molecular Medicine PhD Program, University of South Florida, Tampa, Florida, USA.
  • Ruffell B; Analytic Microscopy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
J Immunother Cancer ; 10(1)2022 01.
Article en En | MEDLINE | ID: mdl-34987021

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Dendríticas / Interleucina-12 / Linfocitos T CD8-positivos / Receptores de Quimiocina / Receptor 2 Celular del Virus de la Hepatitis A / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Dendríticas / Interleucina-12 / Linfocitos T CD8-positivos / Receptores de Quimiocina / Receptor 2 Celular del Virus de la Hepatitis A / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos